Skip to main content
. 2022 Aug 24;14(17):3466. doi: 10.3390/nu14173466

Table 3.

Sarcopenia risk prevalence in adiposity groups.

Characteristics Males,
Years of Age
Females,
Years of Age
p for Difference between Genders
Total
(n = 823)
65–74
(n = 548)
≥75
(n = 275)
Total
(n = 1177)
65–74
(n = 633)
≥75
(n = 544)
BMI (kg/m2), ranges, according to WHO
n(%)
<18.5 1 (33.3%) 1 (50.0%) 0 (0.0%) 3 (30.0%) 2 (28.6%) 1 (33.3%) <0.001
18.5–24.9 28 (11.7%) 9 (5.8%) 19 (22.4%) 62 (16.7%) 15 (7.7%) 47 (26.7%)
25.0–29.9 60 (13.6%) 23 (7.7%) 37 (25.9%) 82 (20.0%) 32 (13.5%) 50 (28.9%)
≥30 20 (14.4%) 6 (6.5%) 14 (30.4%) 116 (30.1%) 36 (18.6%) 80 (41.7%)
BMI (kg/m2), ranges for elderly
n(%)
<22 2 (6.3%) 1 (4.5%) 1 (10.0%) 17 (13.4%) 4 (6.3%) 13 (20.6%) <0.001
22.0–26.9 56 (13.9%) 22 (8.4%) 34 (24.3%) 84 (20.0%) 26 (11.4%) 58 (30.4%)
≥27.0 51 (13.1%) 16 (6.1%) 35 (28.0%) 162 (25.7%) 55 (16.1%) 107 (36.9%)
WC (cm), ranges
n(%)
No data 8 (14.8%) 2 (18.2%) 6 (14.0%) 14 (14.3%) 0 (0.0%) 14 (15.9%) <0.001
<94 (M); <80 (F) 60 (13.7%) 24 (7.5%) 36 (29.8%) 38 (20.8%) 11 (11.7%) 27 (30.3%)
94–102 (M); 80–88 (F) 10 (7.6%) 6 (6.5%) 4 (10.0%) 45 (18.8%) 18 (11.5%) 27 (32.9%)
≥102 (M); ≥88 (F) 31 (15.7%) 7 (5.5%) 24 (33.8%) 166 (25.3%) 56 (15.1%) 110 (32.6%)
WHR, ranges
n(%)
No data 8 (14.8%) 2 (18.2%) 6 (14.0%) 14 (14.3%) 0 (0.0%) 14 (15.9%) 0.02
<0.9 (M); <0.85 (F) 25 (22.9%) 9 (12.5%) 16 (43.2%) 94 (22.9%) 31 (13.6%) 63 (34.4%)
≥0.9 (M); ≥0.85 (F) 76 (11.5%) 28 (6.0%) 48 (24.6%) 155 (23.2%) 54 (13.7%) 105 (37.0%)
WHtR, ranges
n(%)
No data 8 (14.8%) 2 (18.2%) 6 (14.0%) 14 (14.3%) 0 (0.0%) 14 (15.9%) <0.001
≤0.5 38 (14.8%) 18 (9.0%) 20 (34.5%) 46 (16.9%) 16 (9.8%) 30 (27.5%)
>0.5 63 (12.3%) 19 (5.6%) 44 (25.3%) 203 (25.2%) 69 (15.0%) 134 (38.6%)

BMI—body mass index; WC—waist circumference; WHR—waist-to-hip ratio; WHtR—waist-to-height ratio.